Company intelligence / Profile preview

Inovotion

La Tronche, Auvergne-Rhone-Alpes, Franceinovotion.com ↗

Ownership: Private
Development stage: Commercial

Overview

Inovotion provides contract research services using a unique chick embryo xenograft model to rapidly assess the efficacy and toxicity of anticancer drug candidates. Their technology enables early go/no-go decisions before classical rodent studies. They have validated their approach with over 150 R&D studies for academic labs and pharmaceutical/biotech companies. Their assays cover multiple tumor types and can be tailored to specific project needs. The company does not develop its own therapeutic pipeline but supports clients' drug discovery efforts with robust preclinical data.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologicPeptidesAntibodyCell therapy
Industry: Drug Discovery Services

Partnerships

Not specified publicly; works with global pharma/biotech companies and academic labs as clients.

Beyond the preview

Go deeper on Inovotion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inovotion.

Explore the full profile